Manfred Gerlach

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
Manfred Dipl Ing Gerlach
Publication record
27 papers · 1,783 citations · H-index 22

PAPERS

P.7.d.015 Therapeutic drug monitoring (TDM) of fluoxetine in children and adolescents
20130 citationsauthor #5
Transcriptional alterations under continuous or pulsatile dopaminergic treatment in dyskinetic rats
20118 citationsauthor #5
Microglia activation is related to substantia nigra echogenicity
201088 citationsauthor #4
P.1.d.01l Multilevel phenotyping of NOS-I knockdown mice
20090 citationsauthor #5
Evidence for specific phases in the development of human neuromelanin.
200643 citationsauthor #4
Subcellular proteomics reveals neuromelanin granules to be a lysosome-related organelle
200641 citationsauthor #5
Investigation of the lipid component of neuromelanin
20068 citationsauthor #6
Evidence for specific phases in the development of human neuromelanin
200663 citationsauthor #4
Parkinson’s Disease and Related Disorders
200649 citationsauthor #5
Proteomics of the human brain: sub-proteomes might hold the key to handle brain complexity
200629 citationsauthor #5
Neuromelanin induces oxidative stress in mitochondria through release of iron: mechanism behind the inhibition of 26S proteasome
200664 citationsauthor #6
Neuromelanin in human dopamine neurons: comparison with peripheral melanins and relevance to Parkinson's disease.
2005336 citationsauthor #4
Effects of secretin on extracellular amino acid concentrations in rat hippocampus
200433 citationsauthor #6
Quantitation of 5HT3 receptors in forebrain of serotonin transporter deficient mice
200428 citationsauthor #5
Relationships between various behavioural abnormalities and nigrostriatal dopamine depletion in the unilateral 6-OHDA-lesioned rat.
200367 citationsauthor #5
The dopamine receptor agonist lisuride attenuates iron-mediated dopaminergic neurodegeneration.
200332 citationsauthor #7
Influence of neuromelanin on oxidative pathways within the human substantia nigra.
2002102 citationsauthor #6
Brain iron pathways and their relevance to Parkinson's disease
2001184 citationsauthor #2
Expression, but not activity, of neuronal nitric oxide synthase is regionally increased in the alcoholic brain.
200123 citationsauthor #1
Advanced glycation end products in neurodegeneration: More than early markers of oxidative stress?
199881 citationsauthor #2
Pharmacology of selegiline
1996173 citationsauthor #1
Molecular mechanisms for neurodegeneration. Synergism between reactive oxygen species, calcium, and excitotoxic amino acids.
199661 citationsauthor #1
Neuroprotective therapeutic strategies. Comparison of experimental and clinical results.
199543 citationsauthor #1
Pretreatment with nimodipine prevents MPTP-induced neurotoxicity at the nigral, but not at the striatal level in mice.
199584 citationsauthor #2
Neurochemical and behavioural features induced by chronic low dose treatment with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the common marmoset: implications for Parkinson's disease?
199172 citationsauthor #3
Neurochemical and behavioural features induced by chronic low dose treatment with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the common marmoset: implications for Parkinson's disease?
199172 citationsauthor #4
Switching arrangement for gaining a reference value for an independent variable of a known functional course
19720 citationsauthor #1

TIMELINE

1972 0 citations

1991 72 citations

1995 127 citations

1996 234 citations

1998 81 citations

2001 207 citations

2002 102 citations

2003 99 citations

2004 61 citations

2005 336 citations

2006 297 citations

2009 0 citations

2010 88 citations

2011 8 citations

2013 0 citations

Manfred Gerlach

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT